Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Lycia Therapeutics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases. Its immunoglobulin E (IgE) portfolio consists of LCA-0061 and LCA-0062, which are both designed to efficiently degrade IgE for the treatment of allergic diseases, including food allergies. The LCA-0061 is an antibody-small molecule conjugate cataLYTAC degrader designed to target and degrade IgE, a known driver of multiple allergic diseases, including food allergy, allergic asthma, allergic rhinitis, chronic spontaneous urticaria and chronic rhinosinusitis with nasal polyps. The LYTAC platform serves as a drug discovery engine. It produces protein-degrading therapeutics that target extracellular proteins and shuttle them from outside the cell into the lysosome, where they are degraded.
Find out what a historical investment in Lycia Therapeutics would be worth today using our LYCA stock calculator.
Buying LYCA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Lycia Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in LYCA
What is the ticker symbol of Lycia Therapeutics?
The ticker symbol for Lycia Therapeutics is LYCA.
How much is one share of LYCA?
One share of LYCA is valued at $31.77 as of 20 November 2026.
What is the market capitalisation of Lycia Therapeutics LYCA?
As of 20 November 2026 Lycia Therapeutics has a market cap of $1.73B.
What is the 52-week high for Lycia Therapeutics stock?
The Lycia Therapeutics 52-week high stock price is $36.49.
What is the 52-week low for Lycia Therapeutics stock?
The Lycia Therapeutics 52-week low stock price is $22.19.
Can I buy LYCA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LYCA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LYCA on Stake
Buy LYCA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of LYCA from only US$10 with fractional shares